Cleveland Clinic Performs World’s First In-Human Gene Therapy for Hypertrophic Cardiomyopathy
Patient is first person dosed in clinical trial
Related Articles
UH, Cleveland Clinic Host Drug Take-Back Day April 27
To prevent substance misuse and overdose deaths, Cleveland Clinic and UH are collecting unused medications as part of Drug Take-Back Day on April 27.
Cleveland Clinic, IBM’s Cleveland Discovery & Innovation Forum
The Cleveland Discovery & Innovation Forum explores the ecosystem of cutting-edge healthcare and life sciences research powered by high-performance computing, artificial intelligence (AI) and quantum…
Research Ties TMAO Pathway to Chronic Kidney Disease
Large-scale joint study shows striking link between high blood levels of TMAO and chronic kidney disease risk over time.
Research Ties TMAO Pathway to Chronic Kidney Disease
Large-scale joint study shows striking link between high blood levels of TMAO and chronic kidney disease risk over time.
Content is property of Cleveland Clinic and for news media use only. Cleveland Clinic has started using a recently FDA-approved ultrasound device to treat liver…
Web App Effective in Determining Access to Cholesterol-Lowering Drugs
Findings from a new Cleveland Clinic-led study suggests web application can help consumers appropriately determine if they qualify for a statin.
Tsjechische geheime dienst: Rusland betaalde cash aan bevriende Nederlandse en Europese politici
Een vanuit Praag opererende nieuwssite, gerund door een vertrouweling van Poetin, betaalde afgelopen jaar honderdduizenden euro’s aan politici uit onder meer Nederland in ruil voor…
Cleveland Clinic Expands Psychedelic Research and Launches First Psilocybin Trial in Northeast Ohio
Psilocybin is the primary psychoactive compound in magic mushrooms and has been researched in clinical trials for the last two decades. Known as a recreational drug…
’Het is tijd om onze kinderen de kracht van ’nee’ bij te brengen’
Kinderen die beschermd en verwend opgroeien, amper tegengas krijgen of oplossingen bedenken; psycholoog Anahí Israel is bezorgd over de weerbaarheid en zelfredzaamheid van de prille…
’Het is tijd om onze kinderen de kracht van ’nee’ bij te brengen’
Kinderen die beschermd en verwend opgroeien, amper tegengas krijgen of oplossingen bedenken; psycholoog Anahí Israel is bezorgd over de weerbaarheid en zelfredzaamheid van de prille…